Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 2/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2015392 | 0.97 | ALDH1A1 (0.35) | CRBNTRIM24TRIM33ESR1ESR2 | |
| SCHEMBL2015391 | 0.97 | ALDH1A1 (0.35) | CRBNTRIM24TRIM33ESR1ESR2 | |
| SCHEMBL6757693 | 0.88 | CRBN (0.36) | CRBNTRIM24TRIM33ESR1ESR2 | |
| SCHEMBL6757690 | 0.88 | CRBN (0.36) | CRBNTRIM24TRIM33ESR1ESR2 | |
| SCHEMBL11866693 | 0.88 | CRBN (0.36) | CRBN | |
| SCHEMBL1903325 | 0.87 | CRBN (0.33) | CRBNTRIM24TRIM33ALDH1A1 | |
| SCHEMBL3646429 | 0.78 | MEN1 (0.48) | TRIM24TRIM33ALDH1A1 | |
| SCHEMBL2982384 | 0.78 | ALDH1A1 (0.33) | ESR1ESR2ALDH1A1 | |
| SCHEMBL2988042 | 0.78 | ALDH1A1 (0.33) | ESR1ESR2ALDH1A1 | |
| SCHEMBL6614335 | 0.77 | OPRM1 (0.35) | CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151112-A1 | PYRAZOLOPYRIMIDINE DERIVATIVE AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR | 주식회사 티움바이오 | 2024-07-18 | — | — | WO | disclosed |
| CN-117800944-A | Pyridine amide derivative, pharmaceutical composition containing same and medical application of pharmaceutical composition | 苏州阿尔脉生物科技有限公司 | 2024-04-02 | — | — | CN | disclosed |